ArticleJournal for immunotherapy of cancer2020

Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer.

Daan P Hurkmans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.